Skip to main content
SpringerLink
Log in

Development of Tissue-Selective Estrogen Receptor Modulators

  • Conference paper
Organ-Selective Actions of Steroid Hormones

Part of the book series: Ernst Schering Research Foundation Workshop ((SCHERING FOUND,volume 16))

Abstract

The steroid hormone estrogen is a key intracellular modulator of the processes involved in differentiation, homeostasis, and development of female reproductive function (Clark and Peck 1979). In pathological states, estrogen is also involved in the maintenance and progression of cancers (Sunderland and Osborne 1991) and is implicated in the abnormalities of uterine function observed in endometriosis and possibly uterine fibroids (Kettel et al. 1991). The pharmaceutical exploitation of the estrogen receptor (ER) has seen the development of antihormones, compounds which can oppose the function of the natural hormone estrogen (Kedar et al. 1994; Sunderland and Osborne 1991). One such compound, tamoxifen, has found widespread use in the clinic as adjuvant hormonal therapy for breast cancer where it functions as an antagonist of those estrogen-regulated genes responsible for cellular proliferation (Kedar et al. 1994; Sunderland and Osborne 1991). Interestingly, in bone and in the cardiovascular system, tamoxifen exhibits sufficient ER agonist activity to maintain bone mass and cardiovascular tone in postmenopausal women (Love et al. 1992). Because of these favorable activities, along with its breast-selective antagonist activities, tamoxifen is currently being evaluated as a chemopreventative agent in patients who are at high risk for developing breast cancer (Henderson et al. 1993). Unfortunately, its utility for this application may be adversely affected according to a recent study which indicated that 37% of women taking tamoxifen demonstrated histological changes in the endometrium indicative of unopposed ER agonist activity (Kedar et al. 1994).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allan GF, Leng X, Tsai S-T, Weigel NL, Edwards DP, Tsai M-J, O’Malley BW (1992) Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J Biol Chem 267: 19513–19520

    PubMed  CAS  Google Scholar 

  • Arbuckle ND, Dauvois S, Parker MG (1992) Effects of antioestrogens on the DNA binding activity of oestrogen receptor in vitro. Nucleic Acids Res 20: 3849–3844

    Google Scholar 

  • Beato M (1989) Gene regulation by steroid hormones. Cell 56:335–344

    Google Scholar 

  • Beekman JM, Allan GF, Tsai SY, Tsai M-J, O’Malley BW (1993) Transcrip-tional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol Endocrinol 7:1266–1274

    Google Scholar 

  • Berry M, Metzger D, Chambon P (1990) Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 9: 2811–2818

    CAS  Google Scholar 

  • Black LJ, Sato M, Rowley ER, Magee DE, Bekele A, Williams DC, Cullinan GJ, Bendele R, Kaufman FR, Bensch WR, Frolik CA, Termine JD, Bryant HU (1994) Raloxifene (LY 139481) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovaiectomized rats. J Clin Invest 93: 63–93

    Article  PubMed  CAS  Google Scholar 

  • Buratowski S, Hahn S, Sharp PA, Guarante L (1989) Function of a yeast TATA element-binding protein in a mammalian transcription system. Nature 334: 37–42

    Article  Google Scholar 

  • Cavallini B, Huet J, Plassat J-L, Sentenac A, Egly J-M, Chambon P (1988) A yeast activity can substitute for the HeLa cell TATA box factor. Nature 334: 77–80

    Article  PubMed  CAS  Google Scholar 

  • Chin WW (1994) Molecular mechanisms of thyroid hormone action. Thyroid 4: 389–393

    Article  PubMed  CAS  Google Scholar 

  • Clark JH, Peck EJ (1979) Female sex steroids: receptors and function. Monogr Endocrinol 14: 4–36

    Article  Google Scholar 

  • Cooper JP, Roth SY, Simpson RT (1994) The global transcriptional regulators, SSN6 and TUP1, play distinct roles in the establishment of a repressive chromatin structure. Genes Dev 8: 1400–1410

    Article  PubMed  CAS  Google Scholar 

  • Dana SL, Hoener PA, Wheeler DL, Lawrence CL, McDonnell DP (1994) Novel estrogen response elements identified by genetic selection in yeast are differentially responsive to estrogens and antiestrogens in mammalian cells. Mol Endocrinol 8: 1193–1207

    Article  PubMed  CAS  Google Scholar 

  • Dauvois S, Danielian PS, White R, Parker MG (1992) Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci USA 89: 4037–4041

    Article  PubMed  CAS  Google Scholar 

  • Dauvois S, White R, Parker MG (1993) The antiestrogen ICI182780 disrupts estrogen receptor nucleoplasmic shuttling. J Cell Sci 106: 1377–88

    PubMed  CAS  Google Scholar 

  • Draper MW, Flowers DE, fluster WJ, Neild JA (1993) Effects of raloxifene (LY 139481 HCL) on biochemical markers of bone and lipid metabolism in healthy post-menopausal women. Handelstrykkeriet, Aalborg

    Google Scholar 

  • Fawell SE, White R, Hoare S, Sydenham M, Page M, Parker MG (1990) Inhibition of estrogen receptor-DNA binding by the “pure” antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci USA 87: 6883–6887

    Article  PubMed  CAS  Google Scholar 

  • Fuqua SAW, Chamness GC, McGuire WL (1993) Estrogen receptor mutations in breast cancer. J Cell Biochem 51: 135–139

    Article  PubMed  CAS  Google Scholar 

  • Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M (1994) Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264: 1455–1458

    Article  PubMed  CAS  Google Scholar 

  • Henderson BE, Ross RK, Pike MC (1993) Hormonal chemoprevention of cancer in women. Science 259: 633–638

    Article  PubMed  CAS  Google Scholar 

  • Herschbach BM, Arnaud MB, Johnson AD (1994) Transcriptional repression directed by the yeast alpha 2 protein in vitro. Nature 370: 309–311

    Article  PubMed  CAS  Google Scholar 

  • Horikoshi M, Wang CK, Fujii H, Cromlish JA, Weil PA, Roeder RG (1989) Cloning and structure of a yeast gene encoding a general transcription initiation factor TFIID that binds to the TATA box. Nature 341: 299–303

    Article  PubMed  CAS  Google Scholar 

  • Hu HF, Veroni M, DeLuise M, Wakeling A, Sutherland R, Watts CK, Zalcberg JR (1993) Circumvention of tamoxifen resistance by the pure anti-estrogen ICI182,780. Int J Cancer 55: 873–876

    Article  PubMed  CAS  Google Scholar 

  • Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA, Korach KS (1992) Coupling of dual signalling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 89: 4658–4662

    Article  PubMed  CAS  Google Scholar 

  • Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, McLachlan JA (1993) Peptide growth factors elicit estrogen receptor dependent activation of an estrogen-responsive element. Mol Endocrinol 7: 992–998

    Article  PubMed  CAS  Google Scholar 

  • Ing NH, Beekman JM, Tsai SY, Tsai MJ, O’Malley BW (1992) Members of the steroid hormone receptor superfamily interact with TFIIB (5300-II). J Biol Chem 267: 17617–17623

    PubMed  CAS  Google Scholar 

  • Jacq X, Brou C, Lutz Y, Davidson I, Chambon P, Tora L (1994) Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79: 107–117

    Article  PubMed  CAS  Google Scholar 

  • Kedar RP, Bourne TH, Powles TJ, Collins WP, Ashley SE, Cosgrove DO, Cambell S (1994) Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343: 1318–1321

    Article  PubMed  CAS  Google Scholar 

  • Keleher CA, Redd MJ, Schultz J, Carlson M, Johnson AD (1992) Ssn6-Tupl is a general repressor of transcription in yeast. Cell 68: 709–719

    Article  PubMed  CAS  Google Scholar 

  • Kettel LM, Murphy AA, Mortola JF, Liu JH, Ulmann A, Yen SS (1991) Endocrine responses to long-term administration of the anti-progesterone RU486 in patients with pelvic endometriosis. Fertil Steril 56: 402–407

    PubMed  CAS  Google Scholar 

  • Kumar V, Chambon P (1988) The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55: 145–156

    Article  PubMed  CAS  Google Scholar 

  • Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, Carbone PP, DeMets DL (1992) Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326: 852–856

    Article  PubMed  CAS  Google Scholar 

  • Martinez E, Wahli W (1989) Cooperative binding of estrogen receptor to imperfect estrogen-responsive DNA elements correlates with their synergistic hormone-dependent enhancer activity. EMBO J 8: 3781–3791

    CAS  Google Scholar 

  • McDonnell DP, Nawaz Z, O’Malley BW (1991) In situ distinction between steroid receptor binding and transactivation at a target gene. Mol Cell Biol 11: 4350–4355

    PubMed  CAS  Google Scholar 

  • McDonnell DP, Vegeto E, O’Malley BW (1992) Identification of a negative regulatory function for steroid receptors. Proc Natl Acad Sci USA 89: 10563–10567

    Article  PubMed  CAS  Google Scholar 

  • McDonnell D, Vegeto E, Gleeson MAG (1993) Nuclear hormone receptors as targets for new drug discovery. Biotechnology 11: 1256–1261

    PubMed  CAS  Google Scholar 

  • McDonnell DP, Clemm DL, Imhof MO (1994) Definition of the cellular mechanisms which distinguish between hormone and antihormone activated steroid receptors. Semin Cancer Biol 5: 503–513

    Google Scholar 

  • McDonnell DP, Clemm DL, Herman T, Goldman ME, Pike JW (1995) Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 9: 659–669

    Article  PubMed  CAS  Google Scholar 

  • Meyer ME, Pornon A, Ji J, Bocquel MT, Chambon P, Gronemeyer H (1990) Agonist and antagonist properties of RU486 on the functions of the human progesterone receptor. EMBO J 9: 3923–3932

    CAS  Google Scholar 

  • Pham TP, Hwung Y-P, McDonnell DP, O’Malley BW (1991) Transäctivation functions facilitate the disruption of chromatin structure by estrogen receptor derivatives in vivo. J Biol Chem 266: 18179–18187

    PubMed  CAS  Google Scholar 

  • Pham TP, Hwung Y-P, Santiso-Mere D, McDonnell DP, O’Malley BW (1992) Ligand-dependent and independent functions of the transactivation regions of the human estrogen receptor in yeast. Mol Endocrinol 6: 1043–1050

    Article  PubMed  CAS  Google Scholar 

  • Poon D, Weil PA (1993) Immunopurification of yeast TATA-binding protein and associated factors: presence of transcription factor IIIB transcriptional activity. J Biol Chem 268: 15325–15328

    PubMed  CAS  Google Scholar 

  • Pratt WB, Hutchinson KA, Scherrer LW (1992) Steroid receptor folding by heat-shock proteins and composition of the receptor heterocomplex. Trends Endocrinol Metab 3: 326–333

    Article  PubMed  CAS  Google Scholar 

  • Ranish JA, Lane WS, Hahn S (1992) Isolation of two genes that encode subunits of the yeast transcription factor II. Science 255: 1127–1130

    Article  PubMed  CAS  Google Scholar 

  • Ruppert S, Wang EH, Tjian R (1993) Cloning and expression of human TAFII250: a TBP-associated factor implicated in cell-cycle regulation. Nature 362: 175–179

    Article  PubMed  CAS  Google Scholar 

  • Sanchez ER, Hirst M, Scherrer LC, Tang HY, Welsh MJ, Harmon JM, Simmons SSJ, Ringold GM, Pratt WB (1990) Hormone free mouse glucocorticoid receptors overexpressed in Chinese hamster ovary cells are localized to the nucleus and are associated with both hsp70 and hsp90. J. Biol. Chem. 265: 20123–20130

    Google Scholar 

  • Smith CL, Conneely OM, O’Malley BW (1993) Modulation of the ligand-independent activation of the human estrogen receptor by hormone and anti-hormone. Proc Natl Acad Sci USA 90: 6120–6124

    Article  PubMed  CAS  Google Scholar 

  • Smith DF, Toft DO (1993) Steroid receptors and their associated proteins. Mol Endocrinol 7: 4–11

    Article  PubMed  CAS  Google Scholar 

  • Sunderland MC, Osborne CK (1991) Tamoxifen in pre-menopausal patients with metatastic breast cancer: a review. J Clin Oncol 9: 1283–1297

    PubMed  CAS  Google Scholar 

  • Tora L, Gronemeyer H, Turcotte B, Gaub M-P, Chambon P (1988) The N-terminal region of the chicken progesterone receptor specifies target gene activation. Nature 333: 185–188

    Article  PubMed  CAS  Google Scholar 

  • Treitel MA, Carlson M (1995) Repression by SSN6-TUPI is directed by MIG1, a repressor/activator protein. Proc Natl Acad Sci USA 92: 31323136

    Google Scholar 

  • Tsai S-Y, Tsai M-J, O’Malley BW (1989) Cooperative binding of steroid hormone receptors contibutes to transcriptional synergism at target enhancer elements. Cell 57: 443–448

    Article  PubMed  CAS  Google Scholar 

  • Tzamarias D, Struhl K (1994) Functional dissection of the yeast Cyc8-Tupl transcriptional co-repressor complex. Nature 369: 758–761

    Article  PubMed  CAS  Google Scholar 

  • Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP (1994) Human estrogen receptor transcriptional capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8: 2130

    Article  Google Scholar 

  • Wakeling AE, Dukes M, Bowler J (1991) A potent specific pure antiestrogen with clinical potential. Cancer Res 51: 3867–3873

    PubMed  CAS  Google Scholar 

  • Webb P, Lopez GN, Uht RM, Kushner PJ (1995) Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9: 443–456

    Article  PubMed  CAS  Google Scholar 

  • Williams FE, Trumbly RJ (1991) The CYC8 and TUPI proteins involved in glucose repression in Saccharomyces cerevisiae are associated in a protein complex. Mol Cell Biol 11: 3307–3316

    PubMed  CAS  Google Scholar 

  • Ylikomi T, Bocquel MT, Berry M, Gronemeyer H, Chambon P (1992) Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. EMBO J 11: 3681–3694

    CAS  Google Scholar 

Download references

Authors
  1. D. P. McDonnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. A. Lieberman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Norris
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynaecology, Centre for Reproductive Biology, University of Edinburgh, 37 Chalmers Street, EH3 9EW, Edinburgh, Scotland

    D. T. Baird

  2. German Cancer Research Center, Molecular Biology of the Cell I, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany

    G. Schütz

  3. Research Laboratories of Schering AG, 13342, Berlin, Germany

    R. Krattenmacher

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

McDonnell, D.P., Lieberman, B.A., Norris, J. (1995). Development of Tissue-Selective Estrogen Receptor Modulators. In: Baird, D.T., Schütz, G., Krattenmacher, R. (eds) Organ-Selective Actions of Steroid Hormones. Ernst Schering Research Foundation Workshop, vol 16. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-09153-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-09153-1_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-09155-5

  • Online ISBN: 978-3-662-09153-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation